22q11.2 Awareness Day

The small deletion on the long arm (q) of chromosome 22 causes a syndrome with a diverse collection of symptoms. When the genetic basis of 22q11.2 syndrome was identified, it was discovered that several other conditions thought to be different disorders were all in fact part of the same condition.

Also known as DiGeorge syndrome, velocardiofacial syndrome, CATCH22, Opitz G/BBB syndrome and Cayler cardiofacial syndrome, 22q11.2 deletion is often characterized as ‘the most common genetic disorder no one has heard of’. 22q11.2 deletion syndrome has a prevalence of 1 in 2,000 ­that is thought to be an underestimate due to lack of syndrome familiarity and recognition by doctors, and the wide variability of symptoms. It is the second most common genetic disorder after Down syndrome, the most common cause of cleft lip and palate and the second most common cause of developmental delays and heart defects – 1 in 68 children born with a cardiovascular abnormality are diagnosed with a 22q11.2 deletion.

The deleted region is thought to contain 30-40 genes – but could contain nearly 90 genes. The number of genes deleted in an individual varies. Most of these genes have not been well-characterized or characterized at all, but the significant number of genes deleted may be responsible for the variability of the features. Heart defects, learning difficulties, palate abnormalities which lead to feeding and speech difficulties, and immune system problems are the commonest symptoms of 22q11.2 deletion – occurring in over 70% of individuals affected. Other symptoms include low calcium levels which can cause seizures, autoimmune disorders that increase the risk of infections and autoimmune diseases, kidney abnormalities, hearing loss, eye abnormalities, developmental and intellectual delays. Autism spectrum disorders and attention deficit hypersensitivity disorder (ADHD) are also observed. 22q11.2 is also the strongest known genetic risk factor for schizophrenia. Individuals affected by the 22q11.2 deletion usually have difficulty with verbal memory and visual-spatial skills, language and reading comprehension, along with limited social and emotional function. However, they can demonstrate focused attention and excel in computer skills, spelling and grammar due to their tendency to remember well-encoded information. A talent for rhythm and music has also been observed.

4% of the people affected die during infancy – a percentage that has been significantly reduced due to the availability and improvement of cardiovascular surgeries and antibiotics. In adults, mortality rate for people with 22q11.2 deletion is higher than that of the general population. The prognosis is variable depending on disease severity and the specific collection of symptoms in each individual. A multidisciplinary team of doctors is needed to observe the patient throughout their lifetime, observe and address any emerging features.

About 90% of 22q11.2 cases occur sporadically – without any hereditary risk factor. Couples that already have a child with a 22q11.2 deletion but are not affected themselves have less than 1% chance of having another child with the syndrome. People with the disorder can have children with a 50% chance of inheriting the condition to their offspring, as it is inherited in an autosomal dominant manner.

Due to the multidisciplinary care children with the 22q11.2 deletion receive, and the severity of the symptoms, screening and diagnosis at an early age is of paramount importance. Screening during pregnancy and universal neonatal screening can help reduce anxiety and improve medical and psychological preparedness. Although there is no cure for 22q11.2, there are many therapies – speech, language, behavioral, occupational, physical – that can address the developmental, learning and motor delays and improve the outcome and the quality of life for the individual affected and their families.

VERACITY and VERAgene NIPT can detect 22q11.2 deletion syndrome, amongst other common genetic disorders, from the 10th week of pregnancy. NIPT results, possible next steps and clinical management should always be fully discussed with your healthcare provider. To learn more please visit www.nipd.com

For more information on support groups for 22q11.2 syndrome please visit: The 22q Family Foundation https://22qfamilyfoundation.org/, The International 22q11.2 Foundation http://www.22q.org/ and http://www.maxappeal.org.uk/links/22q_groups_around_the_world.

Compiled using information from:

View All Posts

NIPD Genetics - Privacy Policy

General Statement

This Privacy Policy applies only to www.nipd.com and its subdomains (hereafter collectively referred to as “Sites") that link to this policy. NIPD Genetics Sites are owned by NIPD Genetics Public Company Ltd and are operated by NIPD Genetics Public Company Ltd and on occasion by a third-party that is responsible for the technical maintenance of the Sites.

If, you do not agree with this Privacy Policy, please do not access or use any of NIPD Genetics Sites.

NIPD Genetics values your interest in NIPD Genetics, its products and its services. NIPD Genetics takes the protection of your data seriously.

Personal data for purposes of this Privacy Policy, is any information by which you can be individually identified, including, but not limited to, your name, profession, address, e-mail address, and telephone number.

You may contact NIPD Genetics Public Company Ltd at
NIPD Genetics Public Company Ltd
Neas Engomis 31
Engomi, Nicosia
2409, Cyprus

NIPD Genetics Data Protection Officer can be reached at dpo@nipd.com

This Privacy Policy applies only to the Sites as defined above and which are operated by NIPD Genetics. The NIPD Genetics Privacy Policy seeks to inform the users of its Sites of the following:

NIPD Genetics will not use or share your information with anyone, except as described in this Privacy Policy. This Privacy Policy does not apply to any information we might collect by other digital and offline means and or from other digital and offline sources. The use of information collected through our Sites shall be limited to the purposes under this Privacy Policy and our Terms of Use to customers.

This page informs you of our policies regarding the collection, use, and disclosure of personal data when you use our Sites and the choices you have associated with that data.

We use your data to provide and improve the Sites. By using the Sites, you agree to the collection and use of information in accordance with this policy. Unless otherwise defined in this Privacy Policy, terms used in this Privacy Policy have the same meanings as in our Terms and Conditions, accessible from www.nipd.com

Type of personal information NIPD Genetics may collect through its Sites

Information Collection And Use

We collect several different types of information for various purposes to provide and improve our Sites and services to you.

Personal Data

While using NIPD Genetics Sites, you may be asked to provide NIPD Genetics certain personally identifiable information that can be used to contact or identify you ("Personal Information"). Personal Information that might be used to identify you includes, but is not limited to:

If you send us a query via our Contact us form, your email address, the content and any follow up emails are retained indefinitely.

Cookies and Usage Data

Usage Data

We may also collect information how the Sites are accessed and used ("Usage Data"). This Usage Data may include information such as your computer's Internet Protocol address (e.g. IP address), browser type, browser version, the pages of our Sites that you visit, the time and date of your visit, the time spent on those pages, unique device identifiers and other diagnostic data.

Tracking & Cookies Data

We use cookies and similar tracking technologies to track the activity on our Sites and hold certain information.

Cookies are files with small amount of data which may include an anonymous unique identifier. Cookies are sent to your browser from a website and stored on your device. Tracking technologies also used are beacons, tags, and scripts to collect and track information and to improve and analyze our Sites.

You can instruct your browser to refuse all cookies or to indicate when a cookie is being sent. However, if you do not accept cookies, you may not be able to use some portions of our Sites.

Examples of Cookies we use:

Session Cookies. We use Session Cookies to operate our Sites.

Preference Cookies. We use Preference Cookies to remember your preferences and various settings.

Security Cookies. We use Security Cookies for security purposes.

Visitor behavior cookies. To understand how visitors use and navigate the Sites

Keyword cookies. To understand how visitors discover the Sites.

Use of Data

www.nipd.com uses the collected data for various purposes:

Transfer of Data

Your information, including personal data, may be transferred to — and maintained on — computers located outside of your province, country or other governmental jurisdiction where the data protection laws may differ than those from your jurisdiction.

If you are located outside Cyprus and choose to provide information to us, please note that we transfer the data, including personal data, to Cyprus and process it there.

Your consent to this Privacy Policy followed by your submission of such information represents your agreement to that transfer.

www.nipd.com will take all reasonable steps necessary to ensure that your data is treated securely and in accordance with this Privacy Policy and no transfer of your personal data will take place to an organization or a country unless there are adequate controls in place including the security of your data and other personal information.

Disclosure of Data

NIPD Genetics complies with the protection of personal data regulation and will not sale or trade your personal data.

NIPD Genetics may disclose your personal data in the good faith belief that such action is necessary to:

Security of Data

The security of your data is important to us, but remember that no method of transmission over the Internet, or method of electronic storage is 100% secure. While we strive to use commercially acceptable means to protect your Personal Data, we cannot guarantee its absolute security.

Service Providers

We may employ third party companies and individuals to facilitate, maintain or operate our Sites ("Service Providers"), to provide the SItes on our behalf, to perform service-related services or to assist us in analyzing how our Sites is used.

These third parties have access to your Personal Data only to perform these tasks on our behalf and are obligated not to disclose or use it for any other purpose.


We may use third-party Service Providers to monitor and analyze the use of our Sites.

Google Analytics

Google Analytics is a web analytics service offered by Google that tracks and reports website traffic. Google uses the data collected to track and monitor the use of our Service. This data is shared with other Google services. Google may use the collected data to contextualize and personalize the ads of its own advertising network.

You can opt-out of having made your activity on the Service available to Google Analytics by installing the Google Analytics opt-out browser add-on. The add-on prevents the Google Analytics JavaScript (ga.js, analytics.js, and dc.js) from sharing information with Google Analytics about visits activity.

For more information on the privacy practices of Google, please visit the Google Privacy & Terms web page

Access to your personal data, correction, deletion, and Opting Out

You have the right to review, update or delete any of your personal data by sending a request at NIPD Genetics Personal Data Officer pdo@nipd.com

Links to Other Sites

Our Sites may contain links to other sites that are not operated by us. If you click on a third-party link, you will be directed to that third party's site. We strongly advise you to review the Privacy Policy of every site you visit.

We have no control over and assume no responsibility for the content, privacy policies or practices of any third-party sites or services.

Children's Privacy

Our Service does not address anyone under the age of 18 ("Children").

We do not knowingly collect personally identifiable information from anyone under the age of 18. If you are a parent or guardian and you are aware that your Children has provided us with Personal Data, please contact us. If we become aware that we have collected Personal Data from children without verification of parental consent, we take steps to remove that information from our servers.

Changes to This Privacy Policy

We may update our Privacy Policy from time to time. We will notify you of any changes by posting the new Privacy Policy on this page.

We will let you know via email and/or a prominent notice on our Service, prior to the change becoming effective and update the "effective date" at the top of this Privacy Policy.

You are advised to review this Privacy Policy periodically for any changes. Changes to this Privacy Policy are effective when they are posted on this page.

Contact Us

If you have any questions about this Privacy Policy, please contact pdo@nipd.com

Ok got it!